DWTX · Dogwood Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| Sealbond Ltd Director | ▼ Sell | Other | 2,842,638 Shares held | 11/21/2025 | View profile |
| Gregory Scott Duncan CHIEF EXECUTIVE OFFICER | ▲ Buy | Open Market | 57,461 Shares held | 8/17/2023 | View profile |
| William Pridgen | ▲ Buy | Open Market | 52,045 Shares held | 8/21/2023 | View profile |
| Keefer David R | ▲ Buy | Open Market | 5,000 Shares held | 1/4/2022 | View profile |
| De La Rosa Abel | ▲ Buy | Open Market | 4,000 Shares held | 1/7/2022 | View profile |
| Walsh Angela SVP OF FINANCE | ▲ Buy | Open Market | 3,000 Shares held | 5/23/2022 | View profile |
| Thomas John C | ▲ Buy | Open Market | 1,000 Shares held | 1/4/2022 | View profile |
| Whitley Richard James | ▼ Sell | Open Market | 700 Shares held | 12/8/2022 | View profile |
Transaction History
| Sealbond Ltd | ▼ Sell | Other | 21,610,950 | — | 11/21/2025 |
| Sealbond Ltd | ▼ Sell | Other | 2,842,638 | — | 11/21/2025 |
| William Pridgen | ▲ Buy | Open Market | 15,335 | $20K | 8/21/2023 |
| Gregory Scott Duncan | ▲ Buy | Open Market | 25,000 | $31K | 8/17/2023 |
| Whitley Richard James | ▼ Sell | Open Market | 1,800 | $466 | 12/8/2022 |
| Walsh Angela | ▲ Buy | Open Market | 2,000 | $9K | 5/23/2022 |
| Gregory Scott Duncan | ▲ Buy | Open Market | 7,500 | $34K | 5/23/2022 |
| Whitley Richard James | ▲ Buy | Open Market | 500 | $2K | 5/18/2022 |
| William Pridgen | ▲ Buy | Open Market | 241 | $1K | 5/18/2022 |
| William Pridgen | ▲ Buy | Open Market | 13,450 | $59K | 5/17/2022 |
| William Pridgen | ▲ Buy | Open Market | 600 | $3K | 3/29/2022 |
| William Pridgen | ▲ Buy | Open Market | 2,197 | $12K | 3/23/2022 |
| William Pridgen | ▲ Buy | Open Market | 4,180 | $25K | 1/27/2022 |
| De La Rosa Abel | ▲ Buy | Open Market | 4,000 | $24K | 1/7/2022 |
| Whitley Richard James | ▲ Buy | Open Market | 1,800 | $10K | 1/6/2022 |
| Keefer David R | ▲ Buy | Open Market | 5,000 | $29K | 1/4/2022 |
| Thomas John C | ▲ Buy | Open Market | 1,000 | $6K | 1/4/2022 |
| William Pridgen | ▲ Buy | Open Market | 2,215 | $12K | 1/3/2022 |
| Whitley Richard James | ▲ Buy | Open Market | 200 | $1K | 12/23/2021 |
| William Pridgen | ▲ Buy | Open Market | 8,827 | $50K | 12/21/2021 |
| Gregory Scott Duncan | ▲ Buy | Open Market | 5,000 | $28K | 12/21/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Dogwood to Join 2026 Maxim Growth Summit
Dogwood Therapeutics announced it will participate in the 2026 Maxim Growth Summit. The event is aimed at showcasing companies to investors and partners. Participation may raise the company’s profile and provide networking opportunities. The announcement comes as the stock trades near its 14‑touch support level.
Dogwood to Join 2026 Maxim Growth Summit. Dogwood Therapeutics announced it will participate in the 2026 Maxim Growth Summit. The event is aimed at showcasing companies to investors and partners. Participation may raise the company’s profile and provide networking opportunities. The announcement comes as the stock trades near its 14‑touch support level.